Caribou Biosciences, Inc. (NASDAQ:CRBU) Surges 25% Yet Its Low P/S Is No Reason For Excitement
Caribou Wins Pilot Competition With Right at Home, Becoming National Preferred Partner for Rewards & Recognition Across the United States
Is Caribou Biosciences (CRBU) a Promising Gene Editing Stock?
Caribou Coffee's Holiday Menu Introduces Energizing Cranberry Beverages and Festive Favorites
Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August
Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024